Infinium Global Research Cephalosporin Drugs Market | Page 2

A latest report has been added to the wide database of Cephalosporin Drugs Market by Infinium Global Research.
This report studies the Cephalosporin Drugs Market by generation of cephalosporin (first-generation, second-
generation, third-generation, fourth-generation, and fifth-generation cephalosporin), route of drug administration
(injection, oral) market status and outlook of global and major regions, from manufacturers, and end industries.
The objective of the study is to identify market sizes of different segments & countries in recent years and to
forecast the values for the next six years. Cephalosporin Drugs Market provides opportunities in micro markets for
stakeholders to invest along with the detailed analysis of competitive landscape, latest trends, and product
offerings of the major companies in the Cephalosporin Drugs Market. According to the report the Global
Cephalosporin Drugs Market is projected to grow at a CAGR of 13.9% in terms of value over the period of 2017-
2023. The growth in the world market is primarily driven by significant contribution by North America (Leading
region) region to this market.
In 2014, size of the global Cephalosporin drugs market was valued USD XXX million and it is expected to grow with
a CAGR of X.X% over the period of 2017 to 2023 and reach USD XXX million by 2023. Rising prevalence of
infectious diseases, increasing awareness among patients, multiple treatment options and special regulatory
designation for pipeline molecules are considered to be prime factors driving the growth of cephalosporin market.
Stringent government policies, low investment in R&D activities and high generic penetration of these drugs are
the key restraining factors for the growth of the market. Moreover, use of combination therapies for treatment,
development of highly efficient and safe cephalosporin drugs, and increasing incidence of mergers and acquisition
are anticipated to bring more opportunities for the growth of this market. Furthermore, resistance by government
on drug development and weak pipeline molecules are some of the primary challenges faced by the global
Cephalosporin drugs market.
Segments Covered:
The report segments the Cephalosporin drugs market by, generation of cephalosporin and by route of drug
administration. The market segmentation based on generation of cephalosporin includes First-generation
cephalosporin, Second-generation cephalosporin, Third-generation cephalosporin, Fourth-generation
Infinium Global Research